Primary Gliosarcoma of the Cerebellum in a Young Pregnant Woman: Management Challenges and Immunohistochemical Features. (16th July 2019)

• Record Type: Journal Article
• Authors: Meloni, Marco; Serra, Salvatore; Bellisano, Giulia; Syrmos, Nikolaos; Jeyaretna, Sanjeeva; Ganau, Mario
• Other Names: Ishikawa Eiichi Academic Editor.
• Is Part Of: Case reports in surgery. Volume 2019(2019)
• Publication Date: 2019-07-16
• Subjects: Surgery -- Periodicals; Surgery -- Case studies -- Periodicals; Surgical Procedures, Operative; General Surgery; Surgery; Electronic journals; Periodicals; Case studies; Periodicals; Case Reports; Fulltext; Internet Resources; Periodicals; 617
• DOI: 10.1155/2019/7105361
• Languages: English
• ISSNs: 2090-6900

Abstract

Abstract : Background . Gliosarcoma (GS) represents a rare, high-grade (WHO Grade IV), central nervous system neoplasm, characterized by a very poor prognosis. Similar to other high-grade gliomas, GS affects mainly adults in the 5 th -7 th decade of life and presents a higher incidence in males. The most reported locations of GS are the temporal lobe and the frontal lobe, while only eight cases of GS originating from the posterior cranial fossa are reported in the literature. Case Description . We report the first case occurring during pregnancy in a 33-year-old patient. Diagnosis was obtained on the 15 th week of gestation when patient presented with signs and symptoms of life-threatening raised intracranial pressure. Surgical excision was followed by early recurrence and eventually disease progression because the patient refused adjuvant treatment to save her fetus. Conclusions . GS should be considered in the differential diagnosis of posterior cranial fossa tumors with radiological features of meningioma or glioblastoma, even in young patients. To this regard, sarcomas, solitary fibrous tumors, and even metastases should be considered, especially in light of the tendency of GS to give rise to extracranial localizations. Whenever an aggressive management with radical excision and adjuvant treatment is not safely achievable, disease progression is likely to be unavoidable.